Biphasic_JJ
control_NN
of_IN
nuclear_JJ
factor-kappa_NN
B_NN
activation_NN
by_IN
the_DT
T_NN
cell_NN
receptor_NN
complex_NN
:_:
role_NN
of_IN
tumor_NN
necrosis_NN
factor_NN
alpha_NN
._.

The_DT
regulation_NN
of_IN
nuclear_JJ
factor_NN
-LRB-_-LRB-
NF_NN
-RRB-_-RRB-
-_:
kappa_NN
B_NN
activation_NN
by_IN
the_DT
T_NN
cell_NN
receptor_NN
-LRB-_-LRB-
TcR_NN
-RRB-_-RRB-
\/_:
CD3_NN
complex_NN
in_IN
primary_JJ
human_JJ
T_NN
cells_NNS
has_VBZ
been_VBN
studied_VBN
at_IN
various_JJ
times_NNS
after_IN
activation_NN
._.

Only_RB
p50_NN
NF-kappa_NN
B_NN
protein_NN
bound_VBD
the_DT
kappa_NN
B_NN
element_NN
of_IN
interleukin-2_NN
receptor_NN
-LRB-_-LRB-
IL-2R_NN
-RRB-_-RRB-
alpha_NN
chain_NN
promoter_NN
on_IN
resting_VBG
T_NN
cells_NNS
._.

However_RB
,_,
immediately_RB
after_IN
TcR\/CD3_NN
cross-linking_NN
-LRB-_-LRB-
after_IN
approximately_RB
1_CD
h_NN
;_:
immediate_JJ
-RRB-_-RRB-
binding_NN
of_IN
p50_NN
._.
p65_NN
heterodimers_NNS
was_VBD
observed_VBN
._.

p50.c-rel_NN
heterodimers_NNS
were_VBD
also_RB
detected_VBN
bound_VBN
to_TO
this_DT
sequence_NN
at_IN
early_JJ
time_NN
points_NNS
-LRB-_-LRB-
7-16_CD
h_NN
;_:
early_JJ
-RRB-_-RRB-
,_,
and_CC
both_DT
remained_VBD
active_JJ
at_IN
later_JJ
time_NN
points_NNS
-LRB-_-LRB-
40_CD
h_NN
;_:
late_JJ
-RRB-_-RRB-
after_IN
activation_NN
._.

This_DT
regulation_NN
takes_VBZ
place_NN
mainly_RB
at_IN
the_DT
level_NN
of_IN
nuclear_JJ
translocation_NN
of_IN
p65_NN
and_CC
c-rel_NN
,_,
at_IN
immediate_JJ
and_CC
early_JJ
time_NN
points_NNS
._.

Activation_NN
also_RB
induced_VBD
c-rel_NN
and_CC
p105\/p50_NN
mRNA_NN
synthesis_NN
,_,
but_CC
not_RB
p65_NN
mRNA_NN
whose_WP$
expression_NN
was_VBD
constitutive_JJ
._.

Interestingly_RB
,_,
all_PDT
those_DT
early_JJ
and_CC
late_JJ
events_NNS
,_,
but_CC
not_RB
the_DT
immediate_JJ
ones_NNS
,_,
were_VBD
inhibited_VBN
by_IN
a_DT
neutralizing_VBG
anti-tumor_JJ
necrosis_NN
factor_NN
alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
monoclonal_JJ
antibody_NN
._.

Similarly_RB
,_,
cycloheximide_NN
prevented_VBD
the_DT
p65_NN
and_CC
c-rel_NN
translocation_NN
and_CC
consequent_JJ
formation_NN
of_IN
active_JJ
binding_NN
heterodimers_NNS
,_,
at_IN
early_JJ
and_CC
late_JJ
times_NNS
._.

Cyclosporin_NN
A_NN
impaired_VBD
not_RB
only_RB
early_JJ
and_CC
late_JJ
,_,
but_CC
also_RB
immediate_JJ
events_NNS
;_:
however_RB
,_,
addition_NN
of_IN
TNF-alpha_NN
prevented_VBD
all_DT
inhibition_NN
._.

These_DT
results_NNS
indicate_VBP
that_IN
the_DT
regulation_NN
of_IN
NF-kappa_NN
B_NN
activation_NN
during_IN
T_NN
cell_NN
activation_NN
by_IN
TcR\/CD3_NN
signals_NNS
is_VBZ
biphasic_JJ
:_:
TcR\/CD3_NN
triggers_VBZ
its_PRP$
immediate_JJ
translocation_NN
,_,
which_WDT
is_VBZ
transient_JJ
if_IN
no_DT
TNF-alpha_NN
is_VBZ
present_JJ
._.

TNF-alpha_NN
,_,
therefore_RB
,_,
emerges_VBZ
as_IN
the_DT
main_JJ
factor_NN
responsible_JJ
for_IN
a_DT
second_JJ
phase_NN
of_IN
NF-kappa_NN
B_NN
regulation_NN
,_,
controlling_VBG
both_CC
translocation_NN
of_IN
p65_NN
and_CC
c-rel_NN
,_,
and_CC
new_JJ
mRNA_NN
synthesis_NN
for_IN
c-rel_NN
and_CC
p105\/p50_NN
._.

